This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page


    Page   1/1   
  • 2014 Global health care outlook
    The global health care industry is undergoing a period of “glocalization,” a term that combines “globalization” and “localization” to describe the adaptation of global products or services to accommodate the needs of people in a specific locale.
  • 2014 Global life sciences outlook
    Despite heightened regulatory scrutiny, continued pricing pressures and another year of impacts from health care reform in many countries, the global life sciences sector is exhibiting resilience and reinvention.
  • Healthcare 3.0: Healthcare for the new normal
    The human body is a complex system which owes its continued survival to the fact that individual component organs are simultaneously working independently, and yet in unison in a fully integrated and synergistic manner within a self-regulated environment. Deloitte draws a parallel to this metaphor to illustrate key areas within the Healthcare 3.0 model and provide insights on the future and evolving state of healthcare.
  • Shaping the Future: From Meaningful Use to Meaningful User
    With the recent release of Meaningful Use Stage 2 requirements, health care providers may feel increasing pressure on their organisations to achieve the stated goals in order to qualify for available incentive dollars.
  • Physician Payment Sunshine Act: Physicians and life sciences companies coming to terms with transparency?
    Calls for more transparency and disclosure of payments made by the life sciences industry to health care professionals are creating challenges and opportunities for all parties involved in the delivery of health care.
  • Page   1/1   
Stay connected:
More on Deloitte
Learn about our site